Diabetes Care
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Berg, T. J.
Right arrow Articles by Hanssen, K. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Berg, T. J.
Right arrow Articles by Hanssen, K. F.
Social Bookmarking
Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Diabetes Care, Vol 20, Issue 6 1006-1008, Copyright © 1997 by American Diabetes Association

ARTICLES

Increased serum levels of advanced glycation end products (AGEs) in children and adolescents with IDDM

TJ Berg, K Dahl-Jorgensen, PA Torjesen and KF Hanssen
Aker Diabetes Research Center, Aker University Hospital, Oslo, Norway. t.j.berg@ioks.uio.no

OBJECTIVE: To investigate whether the serum levels of advanced glycation end products (AGEs) are increased in IDDM children and adolescents and to study the effect of puberty on serum levels of AGEs (S-AGEs). RESEARCH DESIGN AND METHODS: A total of 68 children and adolescent IDDM patients (age, 13.3 +/- 4.0 years; duration of diabetes, 5.0 +/- 3.6 years; HbA1c, 8.2 +/- 2.0%; Tanner stage [public hair], 1 vs. 2-5, 24/42) recruited from the pediatric outpatient clinic at Aker University Hospital were compared with 25 healthy nondiabetic control subjects. S-AGEs were measured by a fluoremetric immunoassay. RESULTS: S-AGEs were significantly elevated in the diabetic group when compared with the control group (14.4 +/- 3.5 vs. 11.7 +/- 3.0 U/ml, P < 0.002). A significant correlation (r = 0.26, P < 0.04) was found between S-AGEs and HbA1c in the diabetic group but not in the control group. No significant correlation was found between S-AGEs and the duration of diabetes in the diabetic group or S-AGEs and blood glucose concentration or age in either group. We found no difference between S-AGEs in boys and girls and in prepubertal and pubertal diabetic or control subjects. CONCLUSIONS: S-AGEs are increased in young patients with diabetes before puberty. Since AGEs are linked to the pathogenesis of vascular complications, this observation suggests that the pathological processes leading to diabetic late complications start even before puberty.
Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 Eur J EndocrinolHome page
T. Rohrer, E. Stierkorb, S. Heger, B. Karges, K. Raile, K O. Schwab, R. W Holl, and on behalf of the Diabetes-Patienten-Verlaufsdaten
Delayed pubertal onset and development in German children and adolescents with type 1 diabetes: cross-sectional analysis of recent data from the DPV diabetes documentation and quality management system
Eur. J. Endocrinol., November 1, 2007; 157(5): 647 - 653.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
Y. Ding, A. Kantarci, J. A. Badwey, H. Hasturk, A. Malabanan, and T. E. Van Dyke
Phosphorylation of Pleckstrin Increases Proinflammatory Cytokine Secretion by Mononuclear Phagocytes in Diabetes Mellitus
J. Immunol., July 1, 2007; 179(1): 647 - 654.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
A. Galler, G. Muller, R. Schinzel, J. Kratzsch, W. Kiess, and G. Munch
Impact of Metabolic Control and Serum Lipids on the Concentration of Advanced Glycation End Products in the Serum of Children and Adolescents With Type 1 Diabetes, as Determined by Fluorescence Spectroscopy and N{epsilon}-(Carboxymethyl)Lysine ELISA
Diabetes Care, September 1, 2003; 26(9): 2609 - 2615.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
M. Morcos, A. A.R. Sayed, A. Bierhaus, B. Yard, R. Waldherr, W. Merz, I. Kloeting, E. Schleicher, S. Mentz, R. F. Abd el Baki, et al.
Activation of Tubular Epithelial Cells in Diabetic Nephropathy
Diabetes, December 1, 2002; 51(12): 3532 - 3544.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
F. Facchiano, A. Lentini, V. Fogliano, S. Mancarella, C. Rossi, A. Facchiano, and M. C. Capogrossi
Sugar-Induced Modification of Fibroblast Growth Factor 2 Reduces Its Angiogenic Activity in Vivo
Am. J. Pathol., August 1, 2002; 161(2): 531 - 541.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
A. Bierhaus, S. Schiekofer, M. Schwaninger, M. Andrassy, P. M. Humpert, J. Chen, M. Hong, T. Luther, T. Henle, I. Kloting, et al.
Diabetes-Associated Sustained Activation of the Transcription Factor Nuclear Factor-{kappa}B
Diabetes, December 1, 2001; 50(12): 2792 - 2808.
[Abstract] [Full Text] [PDF]

Home page
 Cardiovasc ResHome page
A. Bierhaus, M. A Hofmann, R. Ziegler, and P. P Nawroth
AGEs and their interaction with AGE-receptors in vascular disease and diabetes mellitus. I. The AGE concept
Cardiovasc Res, March 1, 1998; 37(3): 586 - 600.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 1997 by the American Diabetes Association.